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Abstract
We synthesized a series of new naphthalene derivatives: naproxen- and 6-methoxy naphtha-
lene acetic acid-like 1–5. In these compounds the carboxylic function, typical of the classical
NSAIDs, was replaced by a methylsulfonamido (1, 2 and 6a–c) or methylsulfonyl (3–5) group
present in some selective COX-2 inhibitors. We also synthesized compounds 7 and 8 in which
the naphthalene portion was substituted by tetrahydronaphthalene ring. Some of the new
compounds were assayed for their enzymatic inhibitory activity towards cycloxygenase
enzymes. Compounds 4 and 6b, at a concentration of 10 mM exhibit percentage inhibition
values of 65%, 50% and 29%, 87% towards COX-2 and COX-1, respectively. The substitution of
carboxylic group with a mehylsulfonamido or a methylsulfonyl groups does not allow to direct
the selectivity versus to cycloxygenase enzymes.
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Introduction
Non-steroidal anti-inflammatory drugs (NSAIDs) are competitive
inhibitors of the cycloxygenase (COX) enzymes. These enzymes
exist in two isoforms: COX-1, which is constitutive, and COX-2
which is inducible. COX-1 is expressed in the most of tissues and
is involved in physiological production of PGs responsible of
gastric cytoprotection, COX-2 in normal conditions has lower
expression levels in tissues, but its expression is increased during
inflammatory responses. The up-regulation of COX-2 was also
observed in premalignant and malignant conditions of vari-
ous cancers such as breast, prostate and lung ones which
metastasize in the bones1. Particular attention has been recently
focused on the role that COX-2 enzyme could play in Alzheimer’s
diseases (AD)2,3.
After the removal from the market of some selective COX-2
inhibitors (COXIBs), due to their cardiovascular side effects, the
research has focused towards the evaluation of alternative
chemical structures able to maintain the COX inhibitory activity
with reduced side effects4.
With this aim, we synthesized a series of new naphthalene
derivatives naproxene and 6-methoxy naphthalene acetic acid-like
(6-MNA; 1–6; Figure 1). In these compounds, the carboxylic
function, typical of the classical NSAIDs, was replaced by a
methylsulfonamido (1, 2, 6a–c) or methylsulfonyl (3–5) group
present in some selective COX-2 inhibitors as for example NS398
or SC-57666, respectively. We also synthesized the methylsulfo-
namido compounds 7 and 8 in which the naphthalene portion was
substituted by tetrahydronaphthalene ring.
Methods
Chemistry
The synthesis of compounds 1 and 2 were carried out as depicted
in Schemes 1 and 2.
The isocyanate 8, obtained according to the synthetic method
reported in literature5, treated with trifluoroacetic acid in
methylene chloride gave the 2,2,2-trifluoro-N-[1-(6-methoxy-
naphthalen-2-yl)-ethyl]-acetamide 9. Compound 9 by hydrolysis
with potassium carbonate in aqueous methanol afforded the amine
10. By reaction of the derivative 10, with mesyl chloride and
triethylamine, we obtained the desired compound 1.
The N-(6-Methoxy-naphthalen-2-ylmethyl)-methanesulfona-
mide 2 was prepared as shown in Scheme 2. The catalytic
hydrogenation with Pd/C in acid medium of the commercial
available 6-methoxy-naphthalene-2-carbonitrile 11 afforded the
amine 12, which by subsequent treatment with mesyl chloride and
triethylamine furnished the compound 2.
The synthesis of the compounds 3 and 4 are shown in
Schemes 3 and 4.
The reduction of the commercial available 1-(6-methoxy-
naphthalen-2-yl) ethanone 13 with NaBH4 afforded the alcohol
6
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Figure 1. General structure of NS398 and SC5766, 6-MNA, naproxene and new naphthalene 1–6 and tetrahydronaphthalene 7 and 8 compounds.
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14 which was transformed in the corresponding iodine derivative
15. The treatment of compound 15 with the sodium salt of
methane sulfinic acid in presence of tetrabutylammoniumbromide
afforded the methylsulfone 3.
Commercially available 6-Methoxy-naphthalene-2-aldehyde
16 was reduced with diisobutylaluminum hydride to afford the
corresponding alcohol 17. Compound 17 by treatment with NaI
and BF3Et2O afforded the corresponding iodine derivative 18.
The desidered methylsulfone 4 was obtained by treatment with the
sodium salt of methane sulfinic acid of the iodine derivative 18.
Compound 5 was obtained as reported in Scheme 5. The
6-Methoxynaphthylisocyanate 197, prepared from commercially
available 6-methoxy-2-naphthoic acid by Curtius rearrangement
of the corresponding acyl azide, in the presence of trifluoroacetic
acid and methylene chloride, gave the 2,2,2-Trifluoro-N-(6-
methoxy-naphthalen-2-yl)-acetamide 20, which by hydrolysis
with potassium carbonate in aqueous methanol afforded the
desidered amine 21. Compound 21 treated with mesyl chloride
and pyridine, furnished the desired compound 5.
The general synthetic approach to compounds 6a–c is outlined
in Scheme 6. Compound 22 obtained according to the synthetic
method reported in literature8 was treated by thionyl chloride
to obtain the corresponding acid chloride 238. Compound 23
treated with the appropriate benzenic derivatives 24a–c in AlCl3
afforded the 2-nitro-4-benzoyl-naphthalene derivatives 25a–c.
Compounds 25a–c have been reduced by hydrazine hydrate
and Ni/Raney to the corresponding amines 26a–c, and then
treated with mesyl chloride and pyridine to give the desired
derivatives 6a–c.
The synthesis of methylsulfonamides 7 and 8 were reported
in Scheme 7. The catalytic hydrogenation of 6-methoxy-3,4-
dihydro-(1,2)-naphtoquinone-2-oxime 27 with Pd/C in acid
medium and the reduction of 7-methoxy-3,4-dihydro-1H-naphtha-
len-2-one 30 provided the amines 28, 29. The amines 28 and 29
treated with mesyl chloride and triethylamine furnished the
desired compunds 7 and 8.
Biological results and conclusion
For the new compounds 1–4, 6a–b and 7 the inhibitory
activity towards COX-1 and COX-2 was evaluated in vitro
by measuring the PGE2 production on activated J774.2 macro-
phages9. The results are reported in Table 1 together with those
obtained in the same type of test with NS398 as reference drug.
Compounds 4 and 6b at a concentration of 10 mM exhibit
percentage inhibition values of 65% and 50% toward COX-2 and
29% and 87% toward COX-1, while the other compounds resulted
practically inactive. However, it can be seen how similar
structures have completely different activity values as shown
in Table 1 for compounds naproxene-like 2 (0, 13%) and 4 (29%,
65%). These data seem to indicate that in the class of the
naproxene analogues 1–4 only the methylsulfonyl group, in
substitution of the carboxylic function, is suitable for the
interaction towards COX-2.
Regarding the compounds 6a–b the introduction of a chlorine
substituent on the benzoyl group (6b) confers a good inhibitory
activity even if, no COX-1 and COX-2 selectivity, with respect to
the unsubstituted analogue 6a completely devoid of any
cycloxygenase inhibitory activity. In this class of compounds
would seem confirmed the observation that had already been
highlighted for other class of antiinflammatory drugs, namely that
the presence of a halogen on the benzoyl group is able to have a
positive influence on the activity.
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Experimental procedures
Chemistry
Analytical grade reagents and solvent were purchased from Sigma-
Aldrich (St. Louis, MO), and were used as supplied. Solvents were
dried according to standard methods. All chemical reactions were
monitored by thin layer chromatography (TLC) using alumina
plates coated with silica gel 60 F254 (Merck, Darmstadt, Germany)
containing a fluorescent indicator; spots were detected under UV
light (254 nm). Column flash chromatography separations were
performed on silica gel Merck 230–400 mesh ASTM Evaporations
were made in vacuo (rotating evaporator); Na2SO4 was always used
as the drying agent. Melting points were determined by a Kofler
apparatus (A) and are uncorrected. IR spectra for comparison of
compounds were taken as paraffin oil mulls or as liquid films on
a Unicam Mattson 1000 FT-IR spectrometer (Cambridge, UK).
1H-NMR spectra were obtained with a Varian Gemini CTF 20
spectrometer (Mountain View, CA) operating at 80 MHz, at 25 C
in ca. 5% solution of CDCl3. Chemical shifts () are reported in
ppm, coupling constants J are reported in Hertz. The following
abbreviations are used: singlet (s), doublet (d), triplet (t), broad
singlet (bs) and multiplet (m). Elemental analyses were performed
in our analytic laboratory and agree with the theoretical values to
within ± 0.4%. Mass spectrometry data were collected by spectro-
photometer Hewelett Packard 5988A (Palo Alto, CA) by direct
introduction at a nominal electron energy of 70 eV and a source
temperature at 350 C.
2,2,2-Trifluoro-N-[1-(6-methoxynaphthalen-2-yl)-ethyl]-
acetamide (9)
To a solution of 2-(1-Isocyanato-ethyl)-6-methoxynaphthalene 8
(384 mg, 1.69 mmol) in CH2Cl2 (15 ml) was added dropwise
trifluoroacetic acid (0.175 ml, 2.28 mmol). After 10 h at reflux
temperature, the mixture was cooled at room temperature and
then washed with a solution of NaHCO3, dried and filtered to give
9. Yield 84%; m.p.: 175–180 C; IR (, cm1): 3335 (NH), 1700
(C¼O); 1H-NMR : 7.82–7.11 (m, 6H, aromatic-H), 4.85–4.78
(m, 1H, CH), 3.9 (s, 3H, CH3O), 1.85 (bs, 1H, NH), 1.43 (d, 3H,
J¼ 6.4 Hz, CH3); MS: 297 (M+, 30), 185 (100); Anal. Calcd. for
C15H14 F3NO2 (297.27): C, 60.60; H, 4.75; N, 4.71%. Found: C,
61.00; H, 5.07; N, 4.32%.
1-(6-Methoxynaphthalen-2-yl)-ethylamine (10)
To a solution of 2,2,2-trifluoro-N-[1-(6-methoxynaphthalen-2-yl)-
ethyl]-acetamide (9) (331 mg, 1.11 mmol) in MeOH (20 ml) was
added a solution of K2CO3 (255 mg, 1.85 mmol) in H2O/MeOH
(1:1, 5 ml). The resulting mixture was stirred at room temperature
for 48 h, then the solvent was evaporated and the crude residue
was dissolved in CH2Cl2, extracted with HCl 5%, alkalized, and
finally extracted with AcOEt. The organic phase was then dried,
filtered and evaporated, to give an oily residue, which was
purified by transformation in the corresponding hydrochloride
salt, and crystallised from Et2O/HCl. The hydrochloride salt of 10
was converted into a free base by treating an aqueous solution of
the salt with solid KOH and extracting the free base with CHCl3.
The organic layer was washed (H2O) filtered and evaporated to
give 10 as a solid. 10: Yield 64%; m.p.: 77–78 C; 1H-NMR :
7.72–7.06 (m, 6H, Ar), 4.3 (m, 1H, CH), 3.89 (s, 3H, CH3O), 2.5
(bs, 1H, NH), 1.54 (d, 3H, J¼ 6.4 Hz, CH3); MS: 201 (M+, 18),
186 (100); Anal. Calcd. for C13H15NO (201.26): C, 77.58; H,
7.51; N, 6.96%. Found: C, 77.13; H, 7.34; N, 6.98%.
(6-Methoxynaphthalen-2-yl)-methylamine (12)
A solution of 6-methoxynaphthalene-2-carbonitrile 11 (1 g,
5.46 mmol) in CHCl3 (10 ml), absolute EtOH (20 ml) and
37%HCl (1 ml) was hydrogenated for 24 h in presence of Pd/C
(400 mg). The catalyst was removed by filtration. The evaporation
of the ethanolic solution provided 12 as hydrochloride which was
crystallized from MeOH/Et2O. 12: Yield 81%, m.p.: 236–240
C;
IR (, cm1): 2654 (NH2);
1H-NMR (D2O) : 7.90–7.23 (m, 6H,
Ar), 4.05 (m, 2H, CH2), 3.96 (s, 3H, CH3O); MS: 187 (M
+, 100),
171 (38); Anal. Calcd. for C12H13NO
.HCl (223.63) C, 64.43; H,
6.31; N, 6.26%. Found: C, 64.05; H, 5.96; N, 6.10%.
N-[1-(6-Methoxynaphthalen-2-yl)-ethyl]-
methanesulfonamide (1) and N-(6Methoxy-
naphthalen-2-yl)methyl)-methanesulfonamide (2)
To a solution of appropriate hydrochloride salts of 10, 12
(0.72 mmol) and NEt3 (0.2 ml, 1.44 mmol) in anhydrous CH2Cl2
(8 ml) at 0 C, was added dropwise CH3SO2Cl (0.056 ml,
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Table 1. Biological data of compounds 1–4, 6a,b
and 7.
% inhibition PGE2a (10 mM)
Compound COX-1 COX-2
1 0 2.5
2 0 13
3 0 0
4 29 65
6a 0 0
6b 87 50
7 18 7
NS398 59 80
aSee Ref9
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0.72 mmol). The mixture was stirred for 3 h at room temperature
and after evaporated. The residue was dissolved in CH2Cl2,
washed with 5% HCl and H2O. The organic phase was dried
over anhydrous Na2SO4, and the solvent evaporated to afford
the methansulfonamides 1 and 2 which were crystallized by
CHCl3/hexane. 1: Yield 69%; m.p.: 154–155
C; IR (, cm1):
3227 (NH); 1H-NMR : 7.77–7.09 (m, 6H, Ar), 4.73–4.65 (m, 1H,
CH), 3.90 (s, 3H, CH3SO2), 1.57 (s, 1H, NH), 1.54 (d, 3H,
J¼ 6.4 Hz, CH3); MS: 281 (M+2, 1), 280 (M+1, 2), 279 (M+,
20), 185 (100); Anal. Calcd. for C14H17NO3S (279.35) C, 60.19;
H, 6.13; N, 5.01%. Found: C, 59.90; H, 6.06; N, 4.99%. 2: yield
75%; m.p.: 174–175 C; IR (, cm1): 3246 (NH); 1H-NMR :
7.85–7.05 (m, 6H, Ar), 4.32–4.24 (d, 2H, J¼ 6.4 Hz, CH2), 3.88
(s, 3H, CH3O), 2.95 (s, 3H, CH3SO2); MS: 267 (M+2, 1), 266
(M+1, 3), 265 (M+, 28), 185 (100); Anal. Calcd. for C13H15NO3S
(265.33) C, 58.85; H, 5.70; N, 5.28%. Found: C, 59.11; H, 5.93;
N, 5.14%.
1-(6-Methoxynaphthalen-2-yl)-ethanol (14)
To a solution of 1-(6-methoxynaphthalen-2-yl)-ethanone 13
(500 mg, 2.5 mmol) in MeOH (20 ml) was added NaBH4
(277 mg, 7.5 mmol). The reaction mixture was stirred for 8 h, at
r.t then evaporated at reduced pressure. The residue, dissolved
in Et2O/CH2Cl2 (1:1), was washed with H2O, 10% HCl and
with a saturated solution of NaCl. The organic phase was
dried over anhydrous Na2SO4 and after evaporated. The residue
obtained, crystallized from hexane afforded the pure compound
14. 14: Yield 55%; m.p.: 113–114 C6; IR (, cm1): 3338 (OH);
1H-NMR : 7.74–7.07 (m, 6H, Ar), 4.97–5.04 (m, 1H, CH), 3.90
(s, 3H, CH3O), 1.87 (s, 1H, OH), 1.56 (d, 3H, J¼ 6.4 Hz, CH3);
MS: 202 (M+, 54), 144 (100); Anal. Calcd. for C13H14O2 (202.10)
C, 77.20; H, 6.98%. Found: C, 77.05; H, 6.83%.
(6-Methoxynaphthalen-2-yl)-methanol (17)
A solution of 1-(6-Methoxynaphthalen-2-yl)-ethanone 16
(800 mg, 4.3 mmol) in benzene anhydrous, cooled at 0–5 C,
was added slowly dropwise under N2 atmosphere DIBALH
(6.45 mmol). The reaction mixture was stirred at 5 C for 2 h, than
was quenched with MeOH excess. Aluminum salts were removed
by filtration and washed with warm MeOH; the filtrate was
evaporated under reduced pressure. The crude product crystal-
lized by CH2Cl2/hexane, gave pure 17. 17: Yield 81%; m.p.:
116–118 C; IR (, cm1): 3261 (OH); 1H-NMR : 7.74–7.04
(m, 6H, Ar), 4.78 (s, 2H, CH2), 3.89 (s, 3H, CH3O); MS: 188 (M
+,
100), 115 (80); Anal. Calcd. for C12H12O2 (188.08) C, 76.57; H,
6.43%. Found: C, 76.19; H, 6.81%.
2-(1-Iodo-ethyl)-6-methoxynaphthalene (15) and
2-Iodomethyl-6-methoxynaphthalene (18)
To a solution of appropriate alcohol 14, 17 (3.19 mmol) and NaI
(957 mg, 6.38 mmol) in anhydrous CH3CN (25 ml) was added
dropwise, in 15 minutes, BF3 Et2O freshly distilled (9.57 mmol).
The reaction mixture was stirred for 5 h (for compound 15) and
for 45 minutes (for compound 18), then the organic phase was
treated with brine (30 ml), a solution of 15% Na2S2O3 and finally
extracted with Et2O. Ether phase washed with H2O and with
saturated solution of NaCl, dried and evaporated afforded the
iodine derivatives 15 and 18 which were crystallized by hexane
and AcOEt/hexane, respectively. 15: Yield 46%; 1H-NMR :
7.71–7.01 (m, 6H, Ar), 4.73–4.65 (m, 1H, CH), 3.91 (s, 3H,
CH3O), 1.63 (d, 3H, J¼ 6.4 Hz, CH3); MS: 186 (M+-I); Anal.
Calcd. for C13H13IO (312.15) C, 52.02; H, 4.20%. Found: C,
52.34; H, 4.36%. 18: Yield 32%; 1H-NMR : 7.69–7.05 (m, 6H,
Ar), 4.60 (s, 2H, CH2), 3.89 (s, 3H, CH3O); MS: 171 (M
+-I, 100),
128(80); Anal. Calcd. for C12H11IO (298.12) C, 48.35; H, 3.72%.
Found: C, 48.60; H, 4.01%.
2-(1-Methanesulfonyl-ethyl)-6-methoxynaphthalene (3)
and 2-Methanesulfonylmethyl-6-methoxynaphthalene (4)
A solution of the appropriate iodine derivatives 15, 18
(1.04 mmol), CH3SO2Na (111 mg, 1.09 mmol), tetrabutylammo-
niumbromide (351 mg, 1.09 mmol) in anhydrous DMF (8 ml) was
stirred at 80 C for 48 h. After, the reaction mixture was treated
with H2O/ice and extracted with CHCl3. The organic phase,
washed with H2O, dried, evaporated under reduced pressure,
afforded the derivatives 3 and 4 which were crystallized by
CHCl3/hexane. 3: Yield 42%;
1H-NMR : 7.71–7.01 (m, 6H, Ar),
4.85–4.75 (m, 1H, CH), 3.9 (s, 3H, CH3O), 2.74 (s, 3H, CH3SO2),
1.43 (d, 3H, J¼ 6.4 Hz, CH3); MS: 265 (M+1, 0.67), 264 (M+,
3), 185 (100); Anal. Calcd. for C14H16O3S (264.34) C, 63.61; H,
6.10%. Found: C, 63.26; H, 6.45%. 4: Yield 60%; m.p.: 148 C,
1H-NMR : 7.76-7.10 (m, 6H, Ar), 4.35 (s, 2H, CH2), 3.91 (s, 3H,
CH3O), 2.74 (s, 3H, CH3SO2); MS: 251 (M+1, 1), 250 (M
+, 2),
171 (100); Anal. Calcd. for C13H14O3S (250.31) C, 62.38; H,
5.64%. Found: C, 61.99; H, 5.82%.
2,2,2-Trifluoro-N-(6-methoxynaphthalen-2-yl)-
acetamide (20)
To a solution of 2-Isocyanato-6-methoxynaphthalene 19 (337 mg,
1.69 mmol) in CH2Cl2 (15 ml) was added dropwise trifluoroacetic
acid (0.175 ml, 2.28 mmol). The reaction mixture was refluxed at
40 C under stirring for 48 h. The organic solution cooled, washed
with NaHCO3, dried and evaporated under reduced pressure gave
pure 20. 20: Yield 70%; m.p.: 132–140 C, IR (, cm1): 3275
(NH), 1703 (C¼O); 1H-NMR : 7.96–7.45 (m, 6H, Ar), 3.90 (s,
3H, CH3O); MS: 269 (M
+, 100); Anal. Calcd. for C13H10F3NO2
(269.22) C, 58.00; H, 3.74; N, 5.20%. Found: C, 58.33; H, 4.03;
N, 4.85%.
6-Methoxynaphthalen-2-ylamine (21)
To a solution of 2,2,2-Trifluoro-N-(6-methoxynaphthalen-2-yl)-
acetamide 20 (300 mg, 1.85 mmol) in MeOH (20 ml) was added a
solution of K2CO3 (225 mg, 1.85 mmol) in H2O/MeOH (1:1,
5 ml). The mixture was stirred at 40 C for 48 h, then evaporated
under reduced pressure. The residue was dissolved in CH2Cl2
extracted with HCl 5%, alkalized, and finally extracted with
AcOEt. The organic phase, dried and evaporated under reduced
pressure, gave 21 which in presence of Et2O/HCl was transformed
into the corresponding hydrochloride. The hydrochloride salt of
20 was converted into a free base by treating an aqueous solution
of the salt with solid KOH and extracting the free base with
CHCl3 the organic layer was washed (H2O) filtered and
evaporated to give 21 as a solid. 21:Yield 80%; m.p.: 241–
245 C, IR (, cm1): 3384 (NH2), 1703 (C¼O); 1H-NMR :
7.81–7.33 (m, 6H, Ar), 3.90 (s, 3H, CH3O), 2.45 (bs, 1H, NH2);
MS: 173 (M+, 72), 158 (82), 130 (100); Anal. Calcd. for
C11H11NO (173.31) C, 76.28; H, 6.40; N, 8.09%. Found: C, 75.90;
H, 6.70; N, 8.10%.
N-(6-Methoxynaphthalen-2-yl)-methanesulfonamide (5)
To a solution of 6-methoxynaphthalen-2-ylamine 21 (123 mg,
0.71 mmol), pyridine (0.114 ml, 1.42 mmol) in anhydrous CH2Cl2
(8 ml), cooled at 0 C, CH3SO2Cl (0.055 ml, 0.71 mmol) was
added dropwise. The mixture was stirred for 2 h at room
temperature, evaporated under reduced pressure. The residue
obtained was dissolved in CHCl3, washed with H2O and 5% HCl.
Organic phase, dried and evaporated under reduced pressure,
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afforded 5 as a crude oil that was purified by flash chromatog-
raphy on silica gel (EtOAc/n-hexane 1:1). 5: Yield 48%; m.p.:
177–178 C, IR (, cm1): 3324 (NH); 1H-NMR : 7.75–7.08 (m,
6H, Ar), 6.7 (s, 1H, NH), 3.9 (s, 3H, CH3O), 2.77 (s, 3H,
CH3SO2); MS: 253 (M+2,1), 252 (M+1, 2), 251 (M
+, 18), 172
(100); Anal. Calcd. for C12H13NO3S (251.30) C, 57.35; H, 5.21;
N, 5.57%. Found: C, 57.00; H, 5.43; N, 5.28%.
3-Nitro-naphthalene-1-carbonyl chloride (23)
A solution of 3-Nitro-naphthalene-1-carboxylic acid 228 (3 g,
0.014 mol) in SOCl2 (18 ml) was refluxed for 3 h. The thionyl
chloride was evaporated under reduced pressure, and the solid
obtained, triturated with hexane, gave 23 that was purified by
crystallization from CCl4. 23
8: Yield 76%; m.p.: 139–140 C, IR
(, cm1): 1751 (C¼O); 1H-NMR : 8.88–7.69 (m, 6H, Ar); MS:
235 (M+, 0.65), 126 (100).
General procedure for the synthesis of 2 nitro-4-benzoyl-
naphthalenes (25a–c)
To a suspension of 3-nitro-naphthalene-1-carbonyl chloride 23
(1 g, 4.25 mmol) with appropriate benzene derivative 24a–c
was added, at 0 C, in 15 minutes, AlCl3 (851 mg, 6.38 mmol).
The reaction mixture was stirred at room temperature for 15 h,
then triturated in ice, acidified with 37% HCl to pH¼ 2
and extracted with Et2O. The ether phase, washed with 1 N
NaOH, H2O, dried and evaporated under reduced pressure,
gave the respective 2 nitro-4-benzoyl-naphthalenes 25a–c, which
was purified by crystallization from CH3COCH3 for compounds
25a and 25b and isopropanol for compound 25c. 25a: Yield
46%; m.p.: 140-143 C, IR (, cm1): 1665 (C¼O); 1H-NMR
: 9.10–7.46 (m, 11H, Ar); MS: 277 (M+, 20), 105 (100), 77 (70);
Anal. Calcd. for C17H11NO3 (277.27) C, 73.64; H, 4.00;
N, 5.05%. Found: C, 73.39; H, 3.81; N, 5.05%. 25b: Yield 54%;
m.p.: 146-148 C, IR (, cm1): 1672 (C¼O); 1H-NMR : 8.89–
7.37 (m, 10H, Ar); MS: 311 (M+, 20), 139 (100); Anal. Calcd.
for C17H10ClNO3 (311.72) C, 65.50; H, 3.23; N, 4.49%. Found:
C, 65.55; H, 3.61; N, 4.75%. 25c: Yield 30%; m.p.: 155–156 C,
IR (, cm1): 1672 (C¼O); 1H-NMR : 8.90–7.22 (m, 10H, Ar);
MS: 356 (M+, 34), 185 (98), 126 (100); Anal. Calcd. for
C17H10BrNO3 (356.17) C, 57.33; H, 2.83; N, 3.93%. Found: C,
57.65; H, 2.73; N, 3.66%.
General procedure for the synthesis of 4-benzoyl-2-
naphthylamines (26a–c)
To a solution of the opportune 2 nitro-4-benzoyl-naphthalenes
25a–c (1.80 mmol) in absolute EtOH (15 ml) was added a
catalytic portion of Ni-Raney. The suspension was refluxed and
NH2NH2 H2O (0.393 ml, 8.10 mmol) in absolute EtOH (2 ml)
was added dropwise. The mixture was refluxed for 1 h compound
26a, 12 h compound 26b, 8–10 h compound 26c. The suspension
was filtered through celite and evaporated under reduced pressure.
The residue obtained was dissolved in H2O, washed with Et2O
and treated with saturated solution of Et2O/HCl to obtained the
opportune amines 26a–c as hydrochloride, which were purified
by crystallization from MeOH/Et2O. 26a: Yield 57%; m.p.: 117
C,
IR (, cm1): 2613 (NH2), 1665 (C¼O); 1H-NMR : 7.69–7.13 (m,
11H, Ar); MS: 247 (M+-HCl, 92), 115 (100), 105 (58), 77 (78);
Anal. Calcd. for C17H13NO
.HCl (283.75) C, 71.96; H, 4.97; N,
4.94%. Found: C, 71.80; H, 5.25; N, 4.57%. 26b: Yield 45%; m.p.:
144–149 C, IR (, cm1): 2620 (NH2), 1672 (C¼O); 1H-NMR :
7.95–7.15 (m, 10H, Ar); MS: 281 (M+-HCl, 60), 115 (100);
Anal. Calcd. for C17H12ClNO
.HCl (318.20) C, 64.17; H, 4.12; N,
4.40%. Found: C, 54.55; H, 4.46; N, 4.10%. 26c: Yield 40%; m.p.:
119-125 C, IR (, cm1): 2590 (NH2), 1675 (C¼O); 1H-NMR
: 8.10–7.35 (m, 10H, Ar); MS: 325 (M+-HCl, 38), 115 (100);
Anal. Calcd. for C17H12BrNO
.HCl (362.65) C, 56.30; H, 3.61;
N, 3.86%. Found: C, 56.58; H, 3.75; N, 3.51%.
N-(4-benzoyl-2-naphthyl)-methanesulfonamides (6a–c)
The sulfonamides 6a–c were synthesized from 4-benzoyl-2-
naphthylamines 26a–c as previously reported for compound 5 and
were purified by crystallization from Et2O/hexane, CHCl3/Et2O
and AcOEt/hexane respectively. 6a: Yield 51%; m.p.: 48 C, IR
(, cm1): 3270 (NH), 1657 (C¼O); 1H-NMR : 7.86–7.34 (m,
11H, Ar), 7.11 (s, 1H, NH), 3.04 (s, 3H, CH3SO2); MS: 327
(M+2, 8), 326 (M+1, 15), 325 (M+, 50), 77 (100); Anal. Calcd.
for C18H15NO3S (325.38) C, 66.44; H, 4.65; N, 4.30%. Found: C,
66.54; H, 4.87; N, 4.21%. 6b: Yield 40%; m.p.: 135–136 C, IR
(, cm1): 3269 (NH), 1657 (C¼O); 1H-NMR  ppm 7.81–7.23
(m, 10H, Ar), 7.11 (s, 1H, NH), 3.06 (s, 3H, CH3SO2); MS: 361
(M+2, 22), 360 (M+1, 10), 359 (M+, 58), 111 (100), 75 (65);
Anal. Calcd. for C18H14ClNO3S (359.04) C, 60.08; H, 3.92; N,
3.89%. Found: C, 59.78; H, 3.49; N, 3.47%. 6c: Yield 35%; m.p.:
105–115 C, IR (, cm1): 3278 (NH), 1659 (C¼O); 1H-NMR :
7.84–7.22 (m, 10H, Ar), 3.03 (s, 3H, CH3SO2); MS: 406 (M+2,
5), 405 (M+1, 25), 404 (M+, 40), 183 (100); Anal. Calcd. for
C18H14BrNO3S (404.28) C, 53.48; H, 3.49; N, 3.46%. Found: C,
53.37; H, 3.36; N, 3.22%.
6-Methoxy-1,2,3,4-tetrahydro-naphthalen-2-ylamine (28)
A solution of 6-Methoxy-3,4-dihydro-[1,2]-naphthoquinone-2-
oxime 27 (1 g, 4.9 mmol) in MeOH (50 ml) and HCl 10%
(9 ml) was hydrogenated at 50 C at 1 atm in the presence of Pd/C
(500 mg). After 20 h the catalyst was reactivated and the
hydrogenation continued for another 20 h. The reaction mixture
was filtrated and evaporated under reduced pressure. The
crude residue crystallized from EtOH furnished the desired
hydrochloride derivative 28. The hydrochloride salt of 28 was
converted into the free base by treating an aqueous solution
of the salt with solid KOH, then extracting the free bases with
CHCl3. The organic layer washed (H2O) filtered and evaporated
gave 28 as a solid. 28: Yield 60%; m.p.: 230–240 C, IR
(, cm1): 3146, 2621 (NH2);
1H-NMR : 7.22–6.59 (m, 3H, Ar),
3.75 (s, 3H, CH3O), 2.91–2.76 (m, 3H, aliphatic), 1.56–1.26
(m, 4H, aliphatic); MS: 177 (M+, 0.89), 174 (82); Anal. Calcd.
for C11H15NO (177.24) C, 74.54; H, 8.53; N, 7.90%. Found: C,
74.25; H, 8.86; N, 7.61%.
7-Methoxy-1,2,3,4-tetrahydro-naphthalen-2-ylamine (29)
To a solution of 7-Methoxy-3,4-dihydro-1H-naphthalen-2-one 30
(500 mg, 2.84 mmol) in anhydrous MeOH (15 ml) was added
CH3COONH4 (2.19 g, 28.4 mmol) and NaBH3CN (125 mg,
199 mmol). The mixture was stirred for 48 h, then acidified
with HCl (37%) to pH52, evaporated under reduced pressure.
The residue was dissolved in H2O, washed with Et2O, alkalized
and extracted with Et2O. The ether phase, dried and evaporated
under reduce pressure, gave 7-Methoxy-1,2,3,4-tetrahydro-
naphthalen-2-ylamine 29 which, in the presence of Et2O/HCl
was transformed into the corresponding hydrochloride. The
hydrochloride salt of 29 was converted into the free base by
treating an aqueous solution of the salt with solid KOH then
extracting the free base with CHCl3. The organic layer was
washed (H2O) filtered and evaporated to give 29 as a solid. 29:
Yield 52%; m.p.: 220-225 C, IR (, cm1): 3490, 2930 (NH2);
1H-NMR ( ppm): 7.22–6.58 (m, 3H, Ar), 3.75 (s, 3H, CH3O),
2.91–2.76 (m, 3H, aliphatic), 1.57–1.25 (m, 4H, aliphatic); MS:
177 (M+, 0.79), 174 (82); Anal. Calcd. for C11H15NO (177.24) C,
74.54; H, 8.53; N, 7.90%. Found: C, 74.98; H, 8.90; N, 7.55%.
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N-(6-Methoxy-1,2,3,4-tetrahydro-naphthalen-2-yl)-
methanesulfonamide (7) N-(7-Methoxy-1,2,3,4-
tetrahydro-naphthalen-2-yl)-methanesulfonamide (8)
Sulfonamides compounds 7 and 8 were synthesized from
compounds 28 and 29 as previously reported for 1 and 2.
Compounds 7, 8 were purified by crystallization from CH2Cl2/
hexane and CH3COCH3/hexane, respectively. 7: Yield 20%; m.p.:
132–134 C, IR (, cm1): 3268 (NH); 1H-NMR : 6.36–6.71
(m, 3H, Ar), 4.43 (bs, 1H, NH), 3.71 (s, 3H, CH3O), 2.97 (s, 3H,
CH3SO2), 3.04–2.55 (m, 4H, aliphatic), 2.56–2.12 (m, 3H,
aliphatic); MS: 257 (M+2, 0.87), 256 (M+1, 1.76), 255 (M+,
12), 160 (100); Anal. Calcd. C12H17NO3S (255.33) C, 56.45; H,
6.71; N, 5.49%. Found: C, 56.76; H, 6.78; N, 5.21%. 8: Yield
51%; m.p.: 101–108 C, IR (, cm1): 3261 (NH); 1H-NMR :
6.91–6.56 (m, 3H, Ar), 4.5 (bs, 1H, NH), 3.74 (s, 3H, CH3O), 2.98
(s, 3H, CH3SO2), 3.06–2.75 (m, 4H, aliphatic), 2.02 (m, 3H,
aliphatic); MS: 257 (M+2, 1), 256 (M+1, 2), 255 (M+, 10), 160
(100); Anal. Calcd. C12H17NO3S (255.33) C, 56.45; H, 6.71; N,
5.49%. Found: C, 56.13; H, 6.92; N, 5.28%
Enzyme assays
Compounds 1–4, 6a,b and 7 were tested following the procedure
previously described9 in intact cell assays to verify their capacity
to inhibit PGE2 production, considered as an index of activity on
COX-1 and COX-2.
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